Andrew Morris has joined SQI Diagnostics' board of directors.

Morris has been president and CEO of the Toronto-based molecular test developer since June. He replaces SQI founder Peter Lea, who has resigned from the board. SQI said that Lea will continue to serve the company as an adviser.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.